Mindmed
Posted Date: Nov 4, 2024
- Investigator: Jeffrey Strawn
- Specialties:
- Type of Study: Drug
A multicenter randomized double-blind placebo-controlled 12-week trial with a 40-week open-label extension evaluation the efficacy and safety of oral MM120 compared to placebo in the treatment of adults with generalized anxiety disorder.
Criteria:
Null
Keywords:
Generalized Anxiety Disorder, Anxiety
For More Information:
Heidi Schroeder
513-558-4422
heysehk@ucmail.uc.edu